Hemas Holdings (COL:HHL.N0000) ROCE % : 31.38% (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Hemas Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hemas Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was 31.38%.

Hemas Holdings ROCE % Historical Data

The historical data trend for Hemas Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemas Holdings ROCE % Chart

Hemas Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

16.41

9.66

15.68

17.78

25.59

Hemas Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															32.09	26.70	19.29	23.10	31.38

Hemas Holdings ROCE % Calculation

Hemas Holdings's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	11710.953	/	( ( (76307.67 - 33715.678)	+	(98497.883 - 49552.356) )	/ 2 )
	=	11710.953	/	( (42591.992	+	48945.527)	/ 2 )
	=	11710.953	/	45768.7595
	=	25.59 %

Hemas Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	16177.384	/	( ( (94733.889 - 44037.938)	+	(98158.918 - 45733.792) )	/ 2 )
	=	16177.384	/	( ( 50695.951	+	52425.126 )	/ 2 )
	=	16177.384	/	51560.5385
	=	31.38 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Hemas Holdings (COL:HHL.N0000) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hemas Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Hemas Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemas Holdings (COL:HHL.N0000) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Hemas Holdings PLC (COL:HHL.N0000) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 75, Braybrooke Place, Hemas House, Colombo, LKA, 02

Website

https://www.hemas.com

Hemas Holdings PLC holds investments in companies with diversified businesses in Sri Lanka. Its businesses include manufacturing, trading and distributing FMCG products, pharmaceutical products, healthcare products, provision of medical care, operating tourism business, hotel management, airlines, shipping business, IT solutions, among others. It has the following reportable segments: Consumer, Healthcare, Leisure, Travel & Aviation, Mobility, and Other segments. The healthcare segment which generates majority revenue distributes pharmaceuticals, surgical and diagnostics products, and owns and manages hospitals.

Hemas Holdings (COL:HHL.N0000) Headlines

No Headlines